Open AccessDoes gemcitabine-based combination therapy improve the prognosis of unresectable pancreatic cancer?
Author(s) -
Chen Sun
Publication year - 2012
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v18.i35.4944
Subject(s) - gemcitabine , medicine , combination therapy , pancreatic cancer , neutropenia , gastroenterology , oncology , hazard ratio , confidence interval , chemotherapy , cancer
To assess whether gemcitabine-based combination therapy improves the prognosis of unresectable pancreatic cancer compared with gemcitabine treatment alone.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom